Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening

World J Urol. 2024 Mar 16;42(1):167. doi: 10.1007/s00345-024-04905-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Early Detection of Cancer*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Overdiagnosis
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / epidemiology
  • Watchful Waiting

Substances

  • Prostate-Specific Antigen